Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

John Corboy

Concepts (392)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
50
2025
436
8.990
 Why?
Multiple Sclerosis, Relapsing-Remitting
15
2025
73
3.810
 Why?
Immunologic Factors
13
2025
230
2.620
 Why?
Neurology
10
2018
102
2.350
 Why?
Immunosuppressive Agents
10
2024
854
1.630
 Why?
Neuromyelitis Optica
4
2023
129
1.170
 Why?
Natalizumab
11
2021
40
0.960
 Why?
Recurrence
8
2025
1005
0.930
 Why?
Diagnostic Errors
2
2017
162
0.730
 Why?
Internship and Residency
5
2011
1047
0.710
 Why?
Brain
16
2025
2669
0.710
 Why?
Drug Substitution
2
2019
51
0.670
 Why?
Fingolimod Hydrochloride
5
2020
39
0.650
 Why?
Rituximab
4
2020
164
0.620
 Why?
Data Collection
4
2011
647
0.610
 Why?
Dementia, Vascular
3
2009
20
0.600
 Why?
Drug Monitoring
1
2019
216
0.570
 Why?
Early Medical Intervention
1
2017
57
0.540
 Why?
Medication Adherence
2
2019
556
0.530
 Why?
Magnetic Resonance Imaging
24
2025
3386
0.530
 Why?
Early Diagnosis
2
2017
233
0.530
 Why?
Humans
87
2025
129266
0.520
 Why?
Glatiramer Acetate
6
2019
18
0.510
 Why?
Calcinosis
2
2009
231
0.500
 Why?
Physicians
4
2016
859
0.490
 Why?
Postural Balance
3
2018
199
0.470
 Why?
Antibodies, Monoclonal, Humanized
8
2023
758
0.460
 Why?
Fatigue
3
2018
316
0.400
 Why?
Dimethyl Fumarate
3
2020
11
0.380
 Why?
Immunoglobulin G
4
2023
848
0.370
 Why?
Middle Aged
39
2025
31090
0.360
 Why?
Practice Guidelines as Topic
1
2018
1497
0.340
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
26
0.340
 Why?
Adult
43
2025
35495
0.330
 Why?
Withholding Treatment
2
2021
71
0.330
 Why?
Psychiatry
2
2009
178
0.310
 Why?
Cysts
1
2009
108
0.290
 Why?
Demyelinating Diseases
4
2019
84
0.290
 Why?
HIV Long Terminal Repeat
3
2001
10
0.290
 Why?
Education, Medical
1
2011
244
0.290
 Why?
Certification
1
2008
94
0.280
 Why?
Female
49
2025
68551
0.280
 Why?
Autoantibodies
3
2023
1467
0.280
 Why?
Lymphopenia
2
2020
60
0.270
 Why?
Education
2
2007
100
0.270
 Why?
Male
40
2025
63512
0.270
 Why?
Central Nervous System Cysts
1
2006
13
0.270
 Why?
Clinical Trials as Topic
3
2016
1004
0.260
 Why?
Cerebral Arteries
1
2006
60
0.260
 Why?
Single-Blind Method
3
2023
271
0.260
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
49
0.260
 Why?
Cerebrovascular Disorders
1
2006
90
0.250
 Why?
Societies, Medical
4
2019
744
0.250
 Why?
DNA, Viral
2
1998
349
0.250
 Why?
Ethics, Medical
2
2015
78
0.240
 Why?
Treatment Outcome
12
2023
10202
0.240
 Why?
HIV Seropositivity
2
1998
119
0.240
 Why?
Databases, Factual
3
2016
1266
0.230
 Why?
Drug Industry
2
2016
106
0.220
 Why?
Double-Blind Method
4
2023
1875
0.220
 Why?
Conflict of Interest
2
2016
123
0.220
 Why?
AIDS Dementia Complex
3
2001
51
0.210
 Why?
Microglia
2
2024
232
0.210
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
57
0.200
 Why?
Heart Aneurysm
1
2002
10
0.200
 Why?
Quality of Health Care
2
2017
602
0.190
 Why?
B-Lymphocytes
5
2023
815
0.190
 Why?
Heart Septal Defects, Atrial
1
2002
52
0.190
 Why?
Lymphoma
2
2005
196
0.190
 Why?
Interferon beta-1a
2
2019
12
0.180
 Why?
Mental Disorders
2
2007
1028
0.180
 Why?
Neuroimaging
1
2023
278
0.180
 Why?
Education, Medical, Continuing
2
2015
122
0.180
 Why?
Brain Neoplasms
4
2016
1143
0.180
 Why?
Central Nervous System Neoplasms
2
2005
146
0.180
 Why?
Agammaglobulinemia
1
2020
33
0.170
 Why?
Interferon-gamma
1
2023
772
0.170
 Why?
Serum Sickness
1
2019
6
0.160
 Why?
Disease Progression
4
2021
2630
0.160
 Why?
Neutropenia
1
2020
136
0.160
 Why?
Indans
1
2019
11
0.160
 Why?
Oxadiazoles
1
2019
33
0.160
 Why?
Referral and Consultation
1
2005
727
0.160
 Why?
Diagnosis, Differential
4
2023
1432
0.160
 Why?
Adjuvants, Immunologic
3
2015
221
0.150
 Why?
Lymphoma, AIDS-Related
1
1998
14
0.150
 Why?
Salvage Therapy
1
2019
133
0.150
 Why?
Educational Measurement
3
2015
260
0.150
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
252
0.140
 Why?
Herpesvirus 8, Human
1
1998
60
0.140
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
572
0.140
 Why?
Eye Movements
1
2018
59
0.140
 Why?
Young Adult
7
2024
12391
0.140
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.140
 Why?
Physician-Patient Relations
2
2016
538
0.140
 Why?
Patient Selection
2
2015
662
0.140
 Why?
Central Nervous System
2
2005
253
0.140
 Why?
Sarcoma, Kaposi
1
1998
76
0.140
 Why?
Herpesvirus 4, Human
1
2018
154
0.130
 Why?
Aged
9
2024
22032
0.130
 Why?
Nervous System Diseases
2
2024
252
0.130
 Why?
Herpesviridae Infections
1
1998
141
0.130
 Why?
Suicide, Assisted
1
1997
25
0.130
 Why?
Neurologists
1
2016
20
0.130
 Why?
Costs and Cost Analysis
1
2017
201
0.130
 Why?
Cost-Benefit Analysis
2
2016
569
0.130
 Why?
Estriol
1
2015
8
0.130
 Why?
Retrospective Studies
10
2024
14461
0.130
 Why?
Dizziness
2
2018
80
0.120
 Why?
Verbal Learning
2
2013
67
0.120
 Why?
Corpus Callosum
2
2006
66
0.120
 Why?
T-Lymphocytes
1
2023
1933
0.120
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
97
0.120
 Why?
Trust
1
2016
115
0.120
 Why?
Follow-Up Studies
6
2020
4887
0.120
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
49
0.110
 Why?
Exercise Therapy
1
2018
412
0.110
 Why?
Stroke
1
2002
1070
0.110
 Why?
Insurance, Health
1
2016
265
0.110
 Why?
Medication Reconciliation
1
2013
28
0.110
 Why?
CD40 Antigens
1
2014
88
0.110
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
135
0.100
 Why?
JC Virus
1
2013
23
0.100
 Why?
Anti-Inflammatory Agents
2
2006
480
0.100
 Why?
Population Surveillance
1
2016
438
0.100
 Why?
Sensation Disorders
1
2012
32
0.100
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
18
0.100
 Why?
Memory Disorders
1
2013
168
0.100
 Why?
Immunoglobulin Heavy Chains
3
2007
80
0.100
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
37
0.100
 Why?
HIV-1
2
2001
836
0.100
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
16
0.100
 Why?
Glioma
1
2016
347
0.100
 Why?
Optic Nerve
2
2005
64
0.090
 Why?
United States
8
2024
13826
0.090
 Why?
T-Lymphocyte Subsets
1
2014
412
0.090
 Why?
Gadolinium
4
2018
78
0.090
 Why?
Academies and Institutes
1
2011
49
0.090
 Why?
Self-Assessment
1
2011
69
0.090
 Why?
Learning
1
2015
401
0.090
 Why?
Nerve Regeneration
1
2010
62
0.090
 Why?
Fatal Outcome
3
2006
299
0.090
 Why?
Quality of Life
3
2021
2687
0.080
 Why?
Leukocytosis
1
2010
32
0.080
 Why?
Diagnostic Tests, Routine
1
2011
102
0.080
 Why?
Antigens, CD19
3
2007
114
0.080
 Why?
Cranial Nerve Neoplasms
1
1989
7
0.080
 Why?
Hemangioma, Cavernous
1
1989
14
0.080
 Why?
Biomarkers
3
2014
3968
0.080
 Why?
Optic Chiasm
1
1989
18
0.080
 Why?
Severity of Illness Index
3
2014
2740
0.080
 Why?
Central Nervous System Infections
1
2010
35
0.080
 Why?
Exercise Test
1
2012
612
0.080
 Why?
Disease Management
1
2013
588
0.080
 Why?
Guidelines as Topic
1
2011
263
0.080
 Why?
Spinal Cord
3
2023
353
0.080
 Why?
Neuroprotective Agents
1
2009
122
0.070
 Why?
Physical Therapy Modalities
1
2011
291
0.070
 Why?
Practice Patterns, Physicians'
1
2016
1267
0.070
 Why?
Hospital-Physician Relations
1
2007
3
0.070
 Why?
Immunoglobulin Variable Region
2
2004
79
0.070
 Why?
Workload
1
2009
153
0.070
 Why?
Antibodies, Monoclonal
2
2011
1367
0.070
 Why?
Neuropsychological Tests
2
2013
1014
0.070
 Why?
Vasculitis, Central Nervous System
1
2006
14
0.070
 Why?
CD4-Positive T-Lymphocytes
1
1993
1056
0.070
 Why?
Headache Disorders
1
2006
17
0.070
 Why?
Nerve Fibers, Myelinated
1
2006
45
0.070
 Why?
Medical Records
1
2007
170
0.070
 Why?
Syndrome
2
2023
339
0.070
 Why?
Methylprednisolone
1
2006
83
0.060
 Why?
Huntington Disease
1
2007
49
0.060
 Why?
Contrast Media
3
2018
393
0.060
 Why?
Glial Fibrillary Acidic Protein
1
2006
91
0.060
 Why?
International Classification of Diseases
1
2007
122
0.060
 Why?
Intracranial Hemorrhages
1
2006
78
0.060
 Why?
Antibody Formation
1
2007
291
0.060
 Why?
Adolescent
8
2024
20313
0.060
 Why?
Herpes Zoster
1
2010
317
0.060
 Why?
Canada
2
2019
350
0.060
 Why?
Aquaporin 4
1
2006
95
0.060
 Why?
DNA Mutational Analysis
1
2006
385
0.060
 Why?
Fellowships and Scholarships
1
2009
273
0.060
 Why?
RNA, Messenger
1
1992
2703
0.060
 Why?
Health Care Surveys
1
2007
557
0.060
 Why?
Patient Compliance
1
2009
563
0.060
 Why?
Surveys and Questionnaires
4
2016
5384
0.060
 Why?
Teaching
1
2007
214
0.060
 Why?
Neurologic Examination
1
2005
114
0.060
 Why?
Cognition Disorders
1
2009
505
0.060
 Why?
Analysis of Variance
3
2015
1288
0.060
 Why?
Colorado
2
2024
4406
0.060
 Why?
Program Evaluation
1
2009
872
0.060
 Why?
Erythrocytes
1
2010
673
0.060
 Why?
Affect
1
2007
286
0.060
 Why?
Central Nervous System Diseases
1
2005
68
0.060
 Why?
Neutrophils
1
2010
1207
0.060
 Why?
Simvastatin
1
2004
60
0.050
 Why?
Ophthalmoplegia
1
2003
8
0.050
 Why?
Prevalence
2
2024
2553
0.050
 Why?
Proteoglycans
1
2004
109
0.050
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
38
0.050
 Why?
Faculty, Medical
1
2006
260
0.050
 Why?
B-Lymphocyte Subsets
1
2003
74
0.050
 Why?
Neurodegenerative Diseases
1
2024
112
0.050
 Why?
Cyclophosphamide
1
2003
232
0.050
 Why?
Radiography
1
2005
796
0.050
 Why?
Academic Medical Centers
1
2005
474
0.050
 Why?
Students, Medical
1
2006
315
0.050
 Why?
Single-Cell Analysis
1
2024
275
0.050
 Why?
Anticoagulants
1
2006
636
0.050
 Why?
Infusions, Intravenous
1
2023
399
0.050
 Why?
Patient Outcome Assessment
1
2023
124
0.050
 Why?
Induced Pluripotent Stem Cells
1
2024
221
0.050
 Why?
Membrane Glycoproteins
1
2004
476
0.050
 Why?
Lymphoma, B-Cell
2
2005
105
0.050
 Why?
Cross-Sectional Studies
1
2012
5050
0.050
 Why?
Dementia
1
2005
225
0.050
 Why?
Peptides
3
2013
923
0.050
 Why?
CCAAT-Enhancer-Binding Proteins
1
2001
37
0.050
 Why?
Disability Evaluation
2
2014
284
0.050
 Why?
Time Factors
4
2018
6543
0.050
 Why?
Schools, Medical
1
2002
132
0.050
 Why?
Clinical Competence
1
2008
1016
0.050
 Why?
Molecular Sequence Data
3
2004
2835
0.050
 Why?
Antibodies, Antinuclear
1
2001
66
0.040
 Why?
Atrophy
1
2021
171
0.040
 Why?
Pain
1
2007
786
0.040
 Why?
Proteasome Endopeptidase Complex
1
2001
148
0.040
 Why?
Consensus
1
2023
615
0.040
 Why?
Venous Thrombosis
1
2002
175
0.040
 Why?
Mobility Limitation
1
2020
60
0.040
 Why?
Child
5
2016
20785
0.040
 Why?
Interferon-beta
2
2011
89
0.040
 Why?
Lipids
1
2023
625
0.040
 Why?
Lymphocyte Activation
1
2003
1109
0.040
 Why?
Antibodies, Viral
1
2023
601
0.040
 Why?
Maintenance Chemotherapy
1
2019
22
0.040
 Why?
Induction Chemotherapy
1
2019
70
0.040
 Why?
Cerebral Infarction
1
1998
42
0.040
 Why?
Cell Separation
2
2014
316
0.040
 Why?
HIV Seronegativity
1
1998
25
0.040
 Why?
Transplantation, Autologous
1
2019
211
0.040
 Why?
Genes, myc
1
1998
49
0.040
 Why?
Base Sequence
2
2001
2146
0.040
 Why?
Astrocytoma
1
1998
115
0.040
 Why?
In Situ Hybridization
1
2018
296
0.030
 Why?
Gene Library
1
1997
115
0.030
 Why?
Risk Assessment
1
2006
3232
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2018
328
0.030
 Why?
Gene Rearrangement
1
1998
148
0.030
 Why?
Syndecan-1
2
2007
27
0.030
 Why?
Breast Neoplasms
1
2008
2140
0.030
 Why?
Morals
1
1997
69
0.030
 Why?
Managed Care Programs
1
1997
133
0.030
 Why?
Risk Factors
3
2008
9745
0.030
 Why?
Drug Administration Schedule
1
2018
768
0.030
 Why?
Viral Load
1
2018
448
0.030
 Why?
Flow Cytometry
2
2014
1155
0.030
 Why?
Mutation
1
2006
3710
0.030
 Why?
Polymerase Chain Reaction
1
1998
1036
0.030
 Why?
Survival Analysis
1
2018
1269
0.030
 Why?
Sequence Analysis, DNA
1
1997
776
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1276
0.030
 Why?
Child, Preschool
3
2016
10459
0.030
 Why?
Patient Care Team
1
2019
601
0.030
 Why?
Incidence
1
2020
2636
0.030
 Why?
Congresses as Topic
1
2015
216
0.030
 Why?
Propylene Glycols
1
2013
27
0.030
 Why?
Ocular Physiological Phenomena
1
1992
9
0.030
 Why?
HLA-DR Antigens
1
2014
223
0.030
 Why?
Sphingosine
1
2013
40
0.030
 Why?
beta-Galactosidase
1
1992
77
0.030
 Why?
Quality-Adjusted Life Years
1
2013
106
0.030
 Why?
Markov Chains
1
2013
117
0.030
 Why?
Drug Therapy, Combination
1
2015
1040
0.020
 Why?
Mice, Inbred DBA
1
1992
190
0.020
 Why?
Leukocyte Count
1
1993
326
0.020
 Why?
Haplotypes
1
2014
475
0.020
 Why?
Mental Recall
1
2013
191
0.020
 Why?
Organ Specificity
1
1992
295
0.020
 Why?
Comparative Effectiveness Research
1
2013
148
0.020
 Why?
Mice
2
2023
16915
0.020
 Why?
Reference Values
1
2013
793
0.020
 Why?
CD3 Complex
1
2012
103
0.020
 Why?
Animals
3
2023
35309
0.020
 Why?
Ki-67 Antigen
1
2012
108
0.020
 Why?
Thymus Gland
1
1992
308
0.020
 Why?
Intestine, Small
1
1992
150
0.020
 Why?
Mitoxantrone
1
2011
14
0.020
 Why?
Hematologic Tests
1
2011
21
0.020
 Why?
Muscle Stretching Exercises
1
2011
18
0.020
 Why?
Depression
2
2011
1306
0.020
 Why?
Patient Participation
1
2015
414
0.020
 Why?
Clinical Laboratory Techniques
1
2011
94
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1365
0.020
 Why?
Recombinant Fusion Proteins
1
1992
648
0.020
 Why?
Amino Acid Sequence
2
2004
2056
0.020
 Why?
Physical Endurance
1
2011
262
0.020
 Why?
Aged, 80 and over
2
2016
7055
0.020
 Why?
Spinal Cord Neoplasms
1
1989
36
0.020
 Why?
Acyclovir
1
2010
99
0.020
 Why?
Cell Count
1
2010
311
0.020
 Why?
Respiratory Function Tests
1
2011
583
0.020
 Why?
History, 19th Century
1
2009
57
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
55
0.020
 Why?
Pilot Projects
2
2004
1584
0.020
 Why?
Injections
1
2009
174
0.020
 Why?
History, 21st Century
1
2009
183
0.020
 Why?
Autoimmunity
1
2014
862
0.020
 Why?
Electrocardiography
1
2011
608
0.020
 Why?
History, 20th Century
1
2009
291
0.020
 Why?
Gene Expression
1
1992
1466
0.020
 Why?
Age of Onset
1
2009
496
0.020
 Why?
Mice, Transgenic
1
1992
2117
0.020
 Why?
Health
1
2007
74
0.020
 Why?
Memory
1
2009
255
0.020
 Why?
Walking
1
2011
498
0.020
 Why?
Association Learning
1
2007
67
0.020
 Why?
Prognosis
2
2006
3773
0.020
 Why?
Herpesvirus 3, Human
1
2010
331
0.020
 Why?
Cerebral Ventricles
1
2006
50
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2012
857
0.020
 Why?
Motor Skills
1
2007
92
0.020
 Why?
Hypothalamus
1
2006
149
0.020
 Why?
Phenotype
1
2014
3074
0.020
 Why?
Genetics
1
2005
25
0.020
 Why?
Models, Theoretical
1
2009
546
0.020
 Why?
Immunologic Memory
1
2007
349
0.020
 Why?
Hospitalization
1
2015
2052
0.020
 Why?
Neurosciences
1
2005
29
0.010
 Why?
Social Support
1
2009
582
0.010
 Why?
Syndecans
1
2004
5
0.010
 Why?
Internet
1
2009
615
0.010
 Why?
Clinical Protocols
1
2006
254
0.010
 Why?
Image Interpretation, Computer-Assisted
1
2006
253
0.010
 Why?
Anisotropy
1
2004
73
0.010
 Why?
Immune System
1
2005
175
0.010
 Why?
Antiviral Agents
1
2010
712
0.010
 Why?
Plasma Cells
1
2004
66
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
13
0.010
 Why?
Videotape Recording
1
2003
34
0.010
 Why?
Infrared Rays
1
2003
21
0.010
 Why?
Meningitis, Viral
1
2003
21
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
112
0.010
 Why?
Saccades
1
2003
39
0.010
 Why?
Antilymphocyte Serum
1
2003
63
0.010
 Why?
Oligoclonal Bands
1
2003
20
0.010
 Why?
Antigens, CD34
1
2003
88
0.010
 Why?
Astrocytes
1
2005
196
0.010
 Why?
Clone Cells
1
2003
262
0.010
 Why?
Whole-Body Irradiation
1
2003
76
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
126
0.010
 Why?
Feasibility Studies
1
2006
867
0.010
 Why?
Observer Variation
1
2003
315
0.010
 Why?
Immunoglobulins
1
2003
160
0.010
 Why?
Mice, Inbred C57BL
1
1992
5439
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2515
0.010
 Why?
Administration, Oral
1
2004
785
0.010
 Why?
Longitudinal Studies
1
2009
2715
0.010
 Why?
Sex Characteristics
1
2007
736
0.010
 Why?
Age Factors
1
2009
3140
0.010
 Why?
ATPases Associated with Diverse Cellular Activities
1
2001
5
0.010
 Why?
Urinary Tract Infections
1
2003
151
0.010
 Why?
Consensus Sequence
1
2001
73
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
947
0.010
 Why?
Cytomegalovirus Infections
1
2003
189
0.010
 Why?
Biopsy
1
2005
1092
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
20
0.010
 Why?
Infant
1
2015
8975
0.010
 Why?
Cohort Studies
1
2011
5409
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
59
0.010
 Why?
Gene Expression Regulation, Viral
1
2001
90
0.010
 Why?
Predictive Value of Tests
1
2006
1949
0.010
 Why?
Acute Disease
1
2003
978
0.010
 Why?
Research
1
2003
416
0.010
 Why?
Combined Modality Therapy
1
2003
1199
0.010
 Why?
Lung
1
1992
3927
0.010
 Why?
Arachnoid
1
1998
12
0.010
 Why?
Sensitivity and Specificity
1
2003
1839
0.010
 Why?
Survival Rate
1
2003
1869
0.010
 Why?
Virus Replication
1
2001
450
0.010
 Why?
Monocytes
1
2001
551
0.010
 Why?
Models, Biological
1
2005
1722
0.010
 Why?
Binding Sites
1
2001
1250
0.010
 Why?
Case-Control Studies
1
2004
3377
0.010
 Why?
Aging
1
2007
1774
0.010
 Why?
Reproducibility of Results
1
2003
3080
0.010
 Why?
Transcription, Genetic
1
2001
1416
0.010
 Why?
DNA-Binding Proteins
1
2001
1446
0.010
 Why?
Cells, Cultured
1
2001
4077
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (392) concept(s)
_
Co-Authors Expand Description
See all (32) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)